Go SearchAdvanced Search

BYETTA Pen Tutorial

General information about how to prepare and inject BYETTA is also provided in the 5-mcg User Manual or 10-mcg User Manual included with each BYETTA Pen. It is important that you read the full User Manual and the Medication Guide before starting BYETTA therapy and review them each time your prescription is filled.

You should be instructed by a healthcare provider on the proper use and storage of the BYETTA Pen prior to giving yourself an injection. To help reinforce this training, view a step-by-step tutorial and video demonstration that show you how to use the BYETTA Pen, including the proper setup and injection techniques.

If you have questions about using your BYETTA Pen, please refer to the list of BYETTA Pen Frequently Asked Questions. If you are new to BYETTA and still have questions following review of the tutorial and Frequently Asked Questions, you can also speak with a BYETTA specialist about using the BYETTA Pen by calling our Easy Start Line at 1-800-868-1190.

Go to byetta_pen_storage.aspx

Indication

BYETTA is an injectable prescription medicine that may improve blood sugar (glucose) control in adults with type 2 diabetes mellitus, when used with a diet and exercise program.

BYETTA is not insulin and should not be taken instead of insulin. BYETTA can be used with Lantus® (insulin glargine), which is a long-acting insulin, but should not be taken with short- and/or rapid-acting insulin. BYETTA is not for people with type 1 diabetes or people with diabetic ketoacidosis.

Important Safety Information for BYETTA® (exenatide) injection

  • Serious side effects can happen in people who take BYETTA, including inflammation of the pancreas (pancreatitis) which may be severe and lead to death. Before taking BYETTA, tell your healthcare provider if you have had pancreatitis, stones in your gallbladder (gallstones), a history of alcoholism, or high blood triglyceride levels. Call your healthcare provider right away if you have pain in your stomach area (abdomen) that is severe, and will not go away. The pain may happen with or without vomiting and may be felt going from your abdomen through to your back.
  • Your risk for getting low blood sugar is higher if you take BYETTA with another medicine that can cause low blood sugar, such as a sulfonylurea or insulin. The dose of your sulfonylurea or insulin medicine may need to be lowered while you use BYETTA.
  • BYETTA should not be used in people who have severe kidney problems and should be used with caution in people who have had a kidney transplant. BYETTA may cause new or worse problems with kidney function, including kidney failure.
  • Before you use BYETTA, tell your healthcare provider if you have severe problems with your stomach, such as delayed emptying of your stomach (gastroparesis) or problems with digesting food.
  • Do not use BYETTA if you have had an allergic reaction to exenatide or any of the other ingredients in BYETTA. Severe allergic reactions can happen with BYETTA. Stop taking BYETTA and get medical help right away.
  • Tell your healthcare provider if you are pregnant or plan to become pregnant. It is not known if BYETTA will harm your unborn baby. Talk to your healthcare provider first if you are breastfeeding or plan to breastfeed.
  • The most common side effects with BYETTA include nausea, vomiting, diarrhea, feeling jittery, dizziness, headache, acid stomach, constipation, and weakness. Nausea most commonly happens when first starting BYETTA, but may become less over time.

These are not all the side effects with BYETTA. Talk to your healthcare provider about any side effect that bothers you or that does not go away.

Please see the BYETTA Prescribing Information and Medication Guide.

Privacy Statement | Terms of Use | Copyright

02-05-1136-B ©2012 Amylin Pharmaceuticals, Inc.
The BYETTA mark, BYETTA design mark, BYETTA By Your Side mark, and BYETTA By Your Side design mark are registered trademarks of Amylin Pharmaceuticals, Inc.
All other trademarks are property of their respective owners.
This product, or its use, may be covered by one or more U.S. Patents including U.S. Patent Nos. 5,424,286, 6,858,576, 6,872,700, 6,902,744, 6,956,026, 7,297,761, 7,521,423, 7,741,269, in addition to others, including patents pending.
This site is intended for U.S. residents ages 18 and over.